Molly F. Franke

2 ta ish

Harvard University

1. Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis

   Molly F. Franke, Mercedes C. Becerra, Dylan B. Tierney +5

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.027991

2. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

   Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

   Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos

   ABIABI:AkademIndex/2025.review-article.000036